Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001628280-25-017487
Filing Date
2025-04-11
Accepted
2025-04-11 16:06:32
Documents
1
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 3/A wk-form3a_1744401986.html 3/A  
1 FORM 3/A wk-form3a_1744401986.xml 3/A 2486
  Complete submission text file 0001628280-25-017487.txt   4000
Mailing Address C/O AMGEN INC ONE AMGEN CENTER DR THOUSAND OAKS CA 91320-1799
Business Address
WILLIAMS DOUGLAS E (Reporting) CIK: 0001184847 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-42365 | Film No.: 25832115

Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Issuer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)